[go: up one dir, main page]

DK0869184T3 - Vaccine til immunisering mod TBE-virusinfektioner samt en fremgangsmåde til fremstilling deraf - Google Patents

Vaccine til immunisering mod TBE-virusinfektioner samt en fremgangsmåde til fremstilling deraf

Info

Publication number
DK0869184T3
DK0869184T3 DK98107383T DK98107383T DK0869184T3 DK 0869184 T3 DK0869184 T3 DK 0869184T3 DK 98107383 T DK98107383 T DK 98107383T DK 98107383 T DK98107383 T DK 98107383T DK 0869184 T3 DK0869184 T3 DK 0869184T3
Authority
DK
Denmark
Prior art keywords
vaccine
preparation
well
virus infections
immunization against
Prior art date
Application number
DK98107383T
Other languages
English (en)
Inventor
Xaver-Franz Prof Dr Heinz
Steven Dr Allison
Christian Doz Dr Mandl
Christian Prof Dr Kunz
Original Assignee
Baxter Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AT0135294A external-priority patent/AT402897B/de
Priority claimed from AT0087195A external-priority patent/AT405607B/de
Application filed by Baxter Ag filed Critical Baxter Ag
Application granted granted Critical
Publication of DK0869184T3 publication Critical patent/DK0869184T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24161—Methods of inactivation or attenuation
    • C12N2770/24162—Methods of inactivation or attenuation by genetic engineering
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK98107383T 1994-07-08 1995-07-06 Vaccine til immunisering mod TBE-virusinfektioner samt en fremgangsmåde til fremstilling deraf DK0869184T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT0135294A AT402897B (de) 1994-07-08 1994-07-08 Verbesserte vakzine zur immunisierung gegen tbe-virusinfektionen sowie ein verfahren zu dessen herstellung
AT0087195A AT405607B (de) 1995-05-23 1995-05-23 Verbesserte vakzine zur immunisierung gegen tbe-virusinfektionen sowie ein verfahren zu dessen herstellung
EP95890132A EP0691404B1 (de) 1994-07-08 1995-07-06 Vakzine zur Immunisierung gegen TBE-Virusinfektionen sowie ein Verfahren zu dessen Herstellung

Publications (1)

Publication Number Publication Date
DK0869184T3 true DK0869184T3 (da) 2001-12-17

Family

ID=25594155

Family Applications (2)

Application Number Title Priority Date Filing Date
DK98107383T DK0869184T3 (da) 1994-07-08 1995-07-06 Vaccine til immunisering mod TBE-virusinfektioner samt en fremgangsmåde til fremstilling deraf
DK95890132T DK0691404T3 (da) 1994-07-08 1995-07-06 Vaccine til immunisering mod TBE-virusinfektioner samt en fremgangsmåde til fremstilling deraf

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK95890132T DK0691404T3 (da) 1994-07-08 1995-07-06 Vaccine til immunisering mod TBE-virusinfektioner samt en fremgangsmåde til fremstilling deraf

Country Status (9)

Country Link
EP (2) EP0691404B1 (da)
AT (2) ATE206459T1 (da)
CZ (1) CZ282927B6 (da)
DE (2) DE59509667D1 (da)
DK (2) DK0869184T3 (da)
ES (2) ES2165109T3 (da)
FI (2) FI117974B (da)
HU (2) HU219503B (da)
RU (1) RU2150294C1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6258788B1 (en) 1997-11-20 2001-07-10 The United States Of America As Represented By The Secretary Of The Army DNA vaccines against tick-borne flaviviruses
US7425437B2 (en) 1999-11-26 2008-09-16 Crucell Holland B.V. Vaccines against West Nile Virus
CA2481479C (en) 2002-02-26 2012-12-11 Maxygen, Inc. Novel flavivirus antigens
WO2006067122A2 (en) 2004-12-20 2006-06-29 Crucell Holland B.V. Binding molecules capable of neutralizing west nile virus and uses thereof
CA2608058C (en) 2005-05-12 2013-09-10 Crucell Holland B.V. Host cell specific binding molecules capable of neutralizing viruses and uses thereof
HUE027099T2 (hu) 2006-06-06 2016-08-29 Crucell Holland Bv Humán kötõmolekulák staphylococcus elleni ölõaktivitással és alkalmazásuk
EP2219671A4 (en) 2007-11-09 2011-02-09 Salk Inst For Biological Studi USE OF TAM RECEPTOR INHIBITORS AS IMMU ENHANCERS AND TAM ACTIVATORS AS IMMUNOSUPPRESSORS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0284791B1 (de) * 1987-03-20 1995-05-03 IMMUNO Aktiengesellschaft DNA- und RNA-Moleküle des westlichen Subtyps des FSME-Virus, Polypeptide, die von diesen Molekülen codiert werden, und deren Verwendung
MY109299A (en) * 1990-08-15 1996-12-31 Virogenetics Corp Recombinant pox virus encoding flaviviral structural proteins
WO1992003161A1 (en) 1990-08-27 1992-03-05 The United States Of America, Represented By The Secretary, United States Department Of Commerce Flavivirus envelope proteins with increased immunogenicity for use in immunization against virus infection
DK0584348T3 (da) 1992-03-11 2005-09-19 Powderject Vaccines Inc Genetisk vaccine mod immundefektvirusser

Also Published As

Publication number Publication date
HU219503B (hu) 2001-04-28
FI117974B (fi) 2007-05-15
ATE206459T1 (de) 2001-10-15
FI118222B (fi) 2007-08-31
CZ282927B6 (cs) 1997-11-12
RU2150294C1 (ru) 2000-06-10
FI20070041A (fi) 2007-01-17
DE59508988D1 (de) 2001-03-01
EP0691404B1 (de) 2001-01-24
FI953371A (fi) 1996-01-09
HU9903233D0 (en) 1999-11-29
EP0869184A3 (de) 1999-05-12
ATE198909T1 (de) 2001-02-15
EP0691404A2 (de) 1996-01-10
HU9501832D0 (en) 1995-08-28
EP0691404A3 (de) 1997-11-12
FI953371A0 (fi) 1995-07-07
EP0869184A2 (de) 1998-10-07
ES2155510T3 (es) 2001-05-16
CZ176995A3 (en) 1996-01-17
EP0869184B1 (de) 2001-10-04
HUT72395A (en) 1996-04-29
HU224199B1 (hu) 2005-06-28
DK0691404T3 (da) 2001-03-19
DE59509667D1 (de) 2001-11-08
ES2165109T3 (es) 2002-03-01

Similar Documents

Publication Publication Date Title
DE69829668D1 (de) Herstellung und verwendung von rekombinanten influenza a virus m2 konstruktionen und impstoffe
CY1106350T1 (el) Εμβολιο φυματιωσης
DE58906121D1 (de) Rekombinantes Vaccinia-Virus MVA.
DK0561890T3 (da) DNA ekspressionssystemer baseret på alphavira
EP1847549A3 (en) Papillomavirus polyprotein constructs
CY1105600T1 (el) Κατασκευασματα νουκλεϊκων οξεων για γενετικη ανοσοποιηση
FI20070041A (fi) Parannettu rokote Flavivirusinfektioiden vastaiseen immuunisointiin
DK606285D0 (da) Vaccine mod rabies samt fremgangsmaade til fremstilling deraf
HUT71847A (en) Dna molecules encoding aminopeptidase enzymes, vectors and transgenic cells containing dna molecules, immunogenic polypeptides encoding by dna molecules, vaccines against helminth infections containing these peptides and process for the preparation ...
WO2002062296A3 (en) Methods and compositions useful for stimulating an immune response
DK0892054T3 (da) Clostridium perfringens-vaccine
DK457687D0 (da) Antigenisk aktive proteiner og peptider, og vacciner mod virus for felin peritonitis (fipv) med indhold af saadanne proteiner eller peptider
EP0236977A3 (en) Bovine virus diarrhea and hog cholera vaccines
DK0778894T3 (da) Vaccine mod infektiös felin peritonitis
PT729509E (pt) Vacina contra papeira contendo uma estirpe do virus jerryl-lynn
DK381787A (da) Rensede antigener med vaccineegenskaber mod b. pertussis, midler, navnlig rekombinant-dna, til fremstilling deraf og vaccinepraeparater indeholdende disse
MY106940A (en) Allelic variants of plasmodium falciparum merozoite surface antigen.
AR010517A1 (es) Compuestos y metodos para la inmunoterapia y diagnostico de tuberculosis
GB2244273A (en) Allelic variants of plasmodium falciparum merozoite surface antigen.